Literature DB >> 30012613

Suppression of Staphylococcus aureus virulence by a small-molecule compound.

Peng Gao1, Pak Leung Ho1,2, Bingpeng Yan1, Kong Hung Sze1, Julian Davies3, Richard Yi Tsun Kao4,2.   

Abstract

Emerging antibiotic resistance among bacterial pathogens has necessitated the development of alternative approaches to combat drug-resistance-associated infection. The abolition of Staphylococcus aureus virulence by targeting multiple-virulence gene products represents a promising strategy for exploration. A multiplex promoter reporter platform using gfp-luxABCDE dual-reporter plasmids with selected promoters from S. aureus-virulence-associated genes was used to identify compounds that modulate the expression of virulence factors. One small-molecule compound, M21, was identified from a chemical library to reverse virulent S. aureus into its nonvirulent state. M21 is a noncompetitive inhibitor of ClpP and alters α-toxin expression in a ClpP-dependent manner. A mouse model of infection indicated that M21 could attenuate S. aureus virulence. This nonantibiotic compound has been shown to suppress the expression of multiple unrelated virulence factors in S. aureus, suggesting that targeting a master regulator of virulence is an effective way to control virulence. Our results illustrate the power of chemical genetics in the modulation of virulence gene expression in pathogenic bacteria.

Entities:  

Keywords:  ClpP; MRSA; antivirulence; bacterial infection; virulence factors

Mesh:

Substances:

Year:  2018        PMID: 30012613      PMCID: PMC6077739          DOI: 10.1073/pnas.1720520115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Vaccines for Staphylococcus aureus and Target Populations.

Authors:  Clarissa Pozzi; Reuben Olaniyi; Lassi Liljeroos; Ilaria Galgani; Rino Rappuoli; Fabio Bagnoli
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

2.  Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis.

Authors:  Michael E Powers; Russell E N Becker; Anne Sailer; Jerrold R Turner; Juliane Bubeck Wardenburg
Journal:  Cell Host Microbe       Date:  2015-06-10       Impact factor: 21.023

Review 3.  Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus.

Authors:  Dorte Frees; Ulf Gerth; Hanne Ingmer
Journal:  Int J Med Microbiol       Date:  2013-12-01       Impact factor: 3.473

4.  New insights into Staphylococcus aureus stress tolerance and virulence regulation from an analysis of the role of the ClpP protease in the strains Newman, COL, and SA564.

Authors:  Dorte Frees; Julie Hove Andersen; Lene Hemmingsen; Kerttu Koskenniemi; Kristoffer T Bæk; Musemma Kedir Muhammed; Dereje Dadi Gudeta; Tuula A Nyman; Antti Sukura; Pekka Varmanen; Kirsi Savijoki
Journal:  J Proteome Res       Date:  2011-12-12       Impact factor: 4.466

5.  Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus.

Authors:  Jingyuan Feng; Stephan Michalik; Anders N Varming; Julie H Andersen; Dirk Albrecht; Lotte Jelsbak; Stefanie Krieger; Knut Ohlsen; Michael Hecker; Ulf Gerth; Hanne Ingmer; Dorte Frees
Journal:  J Proteome Res       Date:  2013-01-08       Impact factor: 4.466

6.  A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.

Authors:  Chia-I Liu; George Y Liu; Yongcheng Song; Fenglin Yin; Mary E Hensler; Wen-Yih Jeng; Victor Nizet; Andrew H-J Wang; Eric Oldfield
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

7.  Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues.

Authors:  Alice G Cheng; Hwan Keun Kim; Monica L Burts; Thomas Krausz; Olaf Schneewind; Dominique M Missiakas
Journal:  FASEB J       Date:  2009-06-12       Impact factor: 5.191

8.  CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.

Authors:  Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

9.  Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils.

Authors:  Bettina Löffler; Muzaffar Hussain; Matthias Grundmeier; Michaela Brück; Dirk Holzinger; Georg Varga; Johannes Roth; Barbara C Kahl; Richard A Proctor; Georg Peters
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

10.  Construction of a Multiplex Promoter Reporter Platform to Monitor Staphylococcus aureus Virulence Gene Expression and the Identification of Usnic Acid as a Potent Suppressor of psm Gene Expression.

Authors:  Peng Gao; Yanli Wang; Iván Villanueva; Pak Leung Ho; Julian Davies; Richard Yi Tsun Kao
Journal:  Front Microbiol       Date:  2016-08-30       Impact factor: 5.640

View more
  16 in total

1.  The ClpXP Protease Contributes to Staphylococcus aureus Pneumonia.

Authors:  Gyu-Lee Kim; Lavoisier Akoolo; Dane Parker
Journal:  J Infect Dis       Date:  2020-09-14       Impact factor: 5.226

Review 2.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

3.  Hinokiflavone Attenuates the Virulence of Methicillin-Resistant Staphylococcus aureus by Targeting Caseinolytic Protease P.

Authors:  Xiangri Kong; Bingmei Wang; Xiaoyu Chen; Li Wang; Xingye Wang; Juan Hou; Lin Wei; Liyan Sui; Chi Zhang; Jiyu Guan; Yanhe Luan; Wei Wang; Wu Song; Yicheng Zhao
Journal:  Antimicrob Agents Chemother       Date:  2022-07-11       Impact factor: 5.938

4.  Armeniaspirol analogues with more potent Gram-positive antibiotic activity show enhanced inhibition of the ATP-dependent proteases ClpXP and ClpYQ.

Authors:  Michael G Darnowski; Taylor D Lanosky; Puneet Labana; Jordan T Brazeau-Henrie; Nicholas D Calvert; Mark H Dornan; Claudia Natola; André R Paquette; Adam J Shuhendler; Christopher N Boddy
Journal:  RSC Med Chem       Date:  2022-02-14

5.  Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal Infections.

Authors:  Peng Gao; Yuanxin Wei; Sherlock Shing Chiu Tai; Pradeep Halebeedu Prakash; Ho Ting Venice Iu; Yongli Li; Hin Cheung Bill Yam; Jonathan Hon Kwan Chen; Pak Leung Ho; Julian Davies; Richard Yi Tsun Kao
Journal:  Antibiotics (Basel)       Date:  2022-06-17

Review 6.  An Interplay of Multiple Positive and Negative Factors Governs Methicillin Resistance in Staphylococcus aureus.

Authors:  Bohdan L Bilyk; Viralkumar V Panchal; Mariana Tinajero-Trejo; Jamie K Hobbs; Simon J Foster
Journal:  Microbiol Mol Biol Rev       Date:  2022-04-14       Impact factor: 13.044

7.  Cold Atmospheric-Pressure Plasma Caused Protein Damage in Methicillin-Resistant Staphylococcus aureus Cells in Biofilms.

Authors:  Li Guo; Lu Yang; Yu Qi; Gulimire Niyazi; Lingling Huang; Lu Gou; Zifeng Wang; Lei Zhang; Dingxin Liu; Xiaohua Wang; Hailan Chen; Michael G Kong
Journal:  Microorganisms       Date:  2021-05-17

8.  Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance.

Authors:  Haibo Wang; Minji Wang; Xiaohan Xu; Peng Gao; Zeling Xu; Qi Zhang; Hongyan Li; Aixin Yan; Richard Yi-Tsun Kao; Hongzhe Sun
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

9.  Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection.

Authors:  Chunyi Zhou; Fatema Bhinderwala; McKenzie K Lehman; Vinai C Thomas; Sujata S Chaudhari; Kelsey J Yamada; Kirk W Foster; Robert Powers; Tammy Kielian; Paul D Fey
Journal:  PLoS Pathog       Date:  2019-01-04       Impact factor: 6.823

Review 10.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.